ORT B Stock Overview
Provides orthopedic surgical products for use in joint implant surgery in Sweden.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Ortoma AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 9.46 |
| 52 Week High | SEK 17.45 |
| 52 Week Low | SEK 6.32 |
| Beta | 0.83 |
| 11 Month Change | 15.37% |
| 3 Month Change | 0.21% |
| 1 Year Change | 33.62% |
| 33 Year Change | -59.22% |
| 5 Year Change | -82.80% |
| Change since IPO | 121.55% |
Recent News & Updates
Recent updates
Ortoma (STO:ORT B) Is In A Strong Position To Grow Its Business
Oct 25
Ortoma (STO:ORT B) Is Doing The Right Things To Multiply Its Share Price
Sep 20We're Keeping An Eye On Ortoma's (STO:ORT B) Cash Burn Rate
Jun 03We Think Ortoma (NGM:ORT B) Can Afford To Drive Business Growth
Dec 09Ortoma (NGM:ORT B) Is In A Good Position To Deliver On Growth Plans
Aug 17Shareholder Returns
| ORT B | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -15.5% | 2.2% | -1.0% |
| 1Y | 33.6% | 2.1% | 14.0% |
Return vs Industry: ORT B exceeded the Swedish Medical Equipment industry which returned 2.2% over the past year.
Return vs Market: ORT B exceeded the Swedish Market which returned 14.4% over the past year.
Price Volatility
| ORT B volatility | |
|---|---|
| ORT B Average Weekly Movement | 10.8% |
| Medical Equipment Industry Average Movement | 7.8% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in SE Market | 12.6% |
| 10% least volatile stocks in SE Market | 3.6% |
Stable Share Price: ORT B has not had significant price volatility in the past 3 months.
Volatility Over Time: ORT B's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 7 | Linus Byström | www.ortoma.com |
Ortoma AB (publ) provides orthopedic surgical products for use in joint implant surgery in Sweden. It offers Ortoma Treatment Solution (OTS) that is designed to support various orthopedic joint or spine surgeries in the areas of hip, spine, knee, and shoulders and extremities surgeries; OTS Plan, a software that processes and assists surgeons during pre-operative planning and post-operative follow-up; OTS Guide, an intra-operative navigation tool guiding surgeons to place the implant in the pre-operatively planned position; and OTS Follow up that is used as support in the postoperative follow-up of a patient through a low-dose computed tomography of the joint. The company was incorporated in 2001 and is based in Gothenburg, Sweden.
Ortoma AB (publ) Fundamentals Summary
| ORT B fundamental statistics | |
|---|---|
| Market cap | SEK 350.81m |
| Earnings (TTM) | -SEK 30.78m |
| Revenue (TTM) | SEK 61.96m |
5.7x
P/S Ratio-11.4x
P/E RatioIs ORT B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ORT B income statement (TTM) | |
|---|---|
| Revenue | SEK 61.96m |
| Cost of Revenue | SEK 42.23m |
| Gross Profit | SEK 19.73m |
| Other Expenses | SEK 50.51m |
| Earnings | -SEK 30.78m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.83 |
| Gross Margin | 31.84% |
| Net Profit Margin | -49.67% |
| Debt/Equity Ratio | 0% |
How did ORT B perform over the long term?
See historical performance and comparison